AXGN Valuation
AxoGen Inc
$
17.600
- Overview
- Forecast
- Valuation
- Earnings
AXGN Relative Valuation
AXGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AXGN is overvalued; if below, it's undervalued.
Historical Valuation
AxoGen Inc (AXGN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -35.44. The fair price of AxoGen Inc (AXGN) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：17.60
Fair
755.36
PE
1Y
3Y
5Y
Trailing
Forward
26.92
EV/EBITDA
AxoGen Inc. (AXGN) has a current EV/EBITDA of 26.92. The 5-year average EV/EBITDA is 19.09. The thresholds are as follows: Strongly Undervalued below -192.37, Undervalued between -192.37 and -86.64, Fairly Valued between 124.82 and -86.64, Overvalued between 124.82 and 230.55, and Strongly Overvalued above 230.55. The current Forward EV/EBITDA of 26.92 falls within the Historic Trend Line -Fairly Valued range.
119.63
EV/EBIT
AxoGen Inc. (AXGN) has a current EV/EBIT of 119.63. The 5-year average EV/EBIT is 43.93. The thresholds are as follows: Strongly Undervalued below -1660.61, Undervalued between -1660.61 and -808.34, Fairly Valued between 896.20 and -808.34, Overvalued between 896.20 and 1748.47, and Strongly Overvalued above 1748.47. The current Forward EV/EBIT of 119.63 falls within the Historic Trend Line -Fairly Valued range.
3.37
PS
AxoGen Inc. (AXGN) has a current PS of 3.37. The 5-year average PS is 3.19. The thresholds are as follows: Strongly Undervalued below 0.38, Undervalued between 0.38 and 1.78, Fairly Valued between 4.59 and 1.78, Overvalued between 4.59 and 5.99, and Strongly Overvalued above 5.99. The current Forward PS of 3.37 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
AxoGen Inc. (AXGN) has a current P/OCF of 0.00. The 5-year average P/OCF is 128.69. The thresholds are as follows: Strongly Undervalued below -4023.21, Undervalued between -4023.21 and -1947.26, Fairly Valued between 2204.64 and -1947.26, Overvalued between 2204.64 and 4280.59, and Strongly Overvalued above 4280.59. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
AxoGen Inc. (AXGN) has a current P/FCF of 0.00. The 5-year average P/FCF is -4.78. The thresholds are as follows: Strongly Undervalued below -271.44, Undervalued between -271.44 and -138.11, Fairly Valued between 128.55 and -138.11, Overvalued between 128.55 and 261.88, and Strongly Overvalued above 261.88. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
AxoGen Inc (AXGN) has a current Price-to-Book (P/B) ratio of 7.17. Compared to its 3-year average P/B ratio of 4.66 , the current P/B ratio is approximately 54.05% higher. Relative to its 5-year average P/B ratio of 4.77, the current P/B ratio is about 50.29% higher. AxoGen Inc (AXGN) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -5.28%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -6.11% , the current FCF yield is about -100.00% lower.
7.17
P/B
Median3y
4.66
Median5y
4.77
0.62
FCF Yield
Median3y
-5.28
Median5y
-6.11
Competitors Valuation Multiple
The average P/S ratio for AXGN's competitors is , providing a benchmark for relative valuation. AxoGen Inc Corp (AXGN) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 18.26%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of AXGN increased by 25.53% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -73.51 to -171.07.
The secondary factor is the Revenue Growth, contributed 18.26%to the performance.
Overall, the performance of AXGN in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is AxoGen Inc (AXGN) currently overvalued or undervalued?
AxoGen Inc (AXGN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -35.44. The fair price of AxoGen Inc (AXGN) is between NaN to NaN according to relative valuation methord.
What is AxoGen Inc (AXGN) fair value?
How does AXGN's valuation metrics compare to the industry average?
What is the current P/B ratio for AxoGen Inc (AXGN) as of Sep 23 2025?
What is the current FCF Yield for AxoGen Inc (AXGN) as of Sep 23 2025?
What is the current Forward P/E ratio for AxoGen Inc (AXGN) as of Sep 23 2025?